<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29878</article-id><article-id pub-id-type="doi">10.7554/eLife.29878</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Genes and Chromosomes</subject></subj-group></article-categories><title-group><article-title>CRISPRi is not strand-specific at all loci and redefines the transcriptional landscape</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-15473"><name><surname>Howe</surname><given-names>Françoise S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6455-2475</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-91803"><name><surname>Russell</surname><given-names>Andrew</given-names></name><email>ar19@sanger.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-98175"><name><surname>Lamstaes</surname><given-names>Anna R</given-names></name><email>anna.lamstaes@st-hughs.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-91801"><name><surname>El-Sagheer</surname><given-names>Afaf</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8706-1292</contrib-id><email>afaf.el-sagheer@chem.ox.ac.uk</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-91802"><name><surname>Nair</surname><given-names>Anitha</given-names></name><email>anitha.nair@bioch.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-91799"><name><surname>Brown</surname><given-names>Tom</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6538-3036</contrib-id><email>tom.brown@chem.ox.ac.uk</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-8056"><name><surname>Mellor</surname><given-names>Jane</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5196-3734</contrib-id><email>jane.mellor@bioch.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Biochemistry</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Chemistry, Chemistry Research Laboratory</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Chemistry Branch, Faculty of Petroleum and Mining Engineering</institution><institution>Suez University</institution><addr-line><named-content content-type="city">Suez</named-content></addr-line><country>Egypt</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-3033"><name><surname>Shilatifard</surname><given-names>Ali</given-names></name><role>Reviewing Editor</role><aff><institution>Northwestern University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>23</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e29878</elocation-id><history><date date-type="received" iso-8601-date="2017-06-23"><day>23</day><month>06</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-10-22"><day>22</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Howe et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Howe et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-29878-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.29878.001</object-id><p>CRISPRi, an adapted CRISPR-Cas9 system, is proposed to act as a strand-specific roadblock to repress transcription in eukaryotic cells using guide RNAs (sgRNAs) to target catalytically inactive Cas9 (dCas9) and offers an alternative to genetic interventions for studying pervasive antisense transcription. Here, we successfully use click chemistry to construct DNA templates for sgRNA expression and show, rather than acting simply as a roadblock, sgRNA/dCas9 binding creates an environment that is permissive for transcription initiation/termination, thus generating novel sense and antisense transcripts. At <italic>HMS2</italic> in <italic>Saccharomyces cerevisiae</italic>, sgRNA/dCas9 targeting to the non-template strand for antisense transcription results in antisense transcription termination, premature termination of a proportion of sense transcripts and initiation of a novel antisense transcript downstream of the sgRNA/dCas9-binding site. This redefinition of the transcriptional landscape by CRISPRi demonstrates that it is not strand-specific and highlights the controls and locus understanding required to properly interpret results from CRISPRi interventions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>CRISPRi</kwd><kwd>transcription roadblock</kwd><kwd>strand-specificity</kwd><kwd>transcription initiation</kwd><kwd>transcription termination</kwd><kwd>HMS2 and GAL1</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/J001694/2</award-id><principal-award-recipient><name><surname>Brown</surname><given-names>Tom</given-names></name><name><surname>Mellor</surname><given-names>Jane</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>209897/Z/17/Z</award-id><principal-award-recipient><name><surname>Lamstaes</surname><given-names>Anna R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>CRISPR interference (CRISPRi), which uses small guide RNAs to target catalytically dead Cas9 protein to chromatin, disrupts existing transcription units and generates new sites for initiation and termination of transcription on both strands of DNA.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Eukaryotic genomes are pervasively transcribed but the effect of this inter- and intragenic transcription is not fully understood (<xref ref-type="bibr" rid="bib16">Mellor et al., 2016</xref>). Of particular interest is the function of antisense transcription, which alters the chromatin in the vicinity of sense promoters (<xref ref-type="bibr" rid="bib13">Lavender et al., 2016</xref>; <xref ref-type="bibr" rid="bib17">Murray et al., 2015</xref>; <xref ref-type="bibr" rid="bib20">Pelechano and Steinmetz, 2013</xref>), and is associated with repression, activation or no change in levels of the corresponding sense transcript (<xref ref-type="bibr" rid="bib17">Murray et al., 2015</xref>). Discerning the mechanism by which antisense transcription functions in gene regulation is confounded by the difficulty in ablating antisense transcription without direct genetic intervention (<xref ref-type="bibr" rid="bib1">Bassett et al., 2014</xref>). A new approach, CRISPR interference (CRISPRi) (<xref ref-type="bibr" rid="bib23">Qi et al., 2013</xref>), can circumvent these issues by avoiding the need to manipulate endogenous DNA sequences. An endonucleolytically dead version of Cas9 (dCas9) is recruited by single base-pairing guide RNAs (sgRNAs) targeting the non-template (NT) DNA strand, where it blocks transcription strand-specifically at the loci tested (<xref ref-type="bibr" rid="bib14">Lenstra et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Qi et al., 2013</xref>). In a further adaptation, dCas9 fusion with transcriptional repressors or activators allows both negative and positive regulations of transcription, respectively (<xref ref-type="bibr" rid="bib8">Gilbert et al., 2013</xref>; <xref ref-type="bibr" rid="bib7">Gilbert et al., 2014</xref>), but the strand-specificity is lost and thus is not suitable for strand-specific repression of antisense transcription. The sgRNA compenent of the CRISPRi system consists of two regions: a constant region (82 nt) that binds to dCas9 and a variable region (20 nt) that is responsible for targeting. The modular nature of the sgRNA lends itself to production from DNA templates constructed using synthetic copper(I)-catalysed alkyne-azide cycloaddition (CuAAC) click chemistry (<xref ref-type="bibr" rid="bib4">El-Sagheer and Brown, 2010</xref>). The stable artificial triazole DNA linker generated is biocompatibile, being read and accurately copied by DNA and RNA polymerases (<xref ref-type="bibr" rid="bib2">Birts et al., 2014</xref>; <xref ref-type="bibr" rid="bib5">El-Sagheer and Brown, 2011</xref>; <xref ref-type="bibr" rid="bib6">El-Sagheer et al., 2011</xref>). We show that click chemistry is an efficient method for sgRNA template construction and that when combined with dCas9, these sgRNAs are as effective as sgRNAs produced from chemically synthesised full-length DNA templates at reducing levels of transcripts in vivo. However, it is still not completely understood how the CRISPRi system functions strand-specifically or why sgRNAs must target the non-template strand.</p><p>Here, we use the CRISPRi system to study the effect of blocking antisense transcription at loci with well-characterised sense:antisense transcript pairs. We have previously used a promoter deletion of the antisense transcript <italic>SUT650</italic> at the <italic>HMS2</italic> locus to show that <italic>SUT650</italic> represses <italic>HMS2</italic> sense transcription (<xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>). Now we use CRISPRi to examine the effects of blocking <italic>SUT650</italic> antisense transcription to ask (i) whether <italic>SUT650</italic> represses <italic>HMS2</italic> sense transcription <italic>without</italic> a genetic intervention and (ii) whether CRISPRi is strand-specific using, in addition to <italic>HMS2</italic>, an engineered <italic>GAL1</italic> gene with a well-characterised antisense transcript (<xref ref-type="bibr" rid="bib18">Murray et al., 2012</xref>, <xref ref-type="bibr" rid="bib17">2015</xref>).</p><p>The main conclusion from this study is that CRISPRi at the <italic>HMS2</italic> locus is not fully strand-specific and results in (i) premature termination of the sense transcript and (ii) initiation of a new unstable antisense transcript in the vicinity of the sgRNA binding site. As transcription from this new antisense initiation site extends in to the <italic>HMS2</italic> promoter, there is no net change in <italic>HMS2</italic> sense transcript levels. Thus, CRISPRi redefines the transcriptional landscape at <italic>HMS2</italic>. This suggests that routine use of CRISPRi for gene expression analysis will require rigorous analysis of transcript integrity and function before conclusions can be drawn.</p></sec><sec id="s2" sec-type="results|discussion"><title>Results and discussion</title><sec id="s2-1"><title>DNA templates for sgRNA production can be made using click chemistry</title><p>CRISPRi-mediated transcriptional repression requires co-expression of a mature sgRNA and dCas9 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). A small library of single-stranded DNAs, comprised of templates for sgRNA variable regions, were joined to the constant region using click chemistry (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) and used successfully as templates for PCR, with no significantly different efficiencies when compared to control full-length synthesised oligonucleotides (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The PCR products were inserted in place of a <italic>URA3</italic> selection cassette in the endogenous <italic>snR52</italic> locus for expression of a transcript that is then processed to form the mature nuclear-retained sgRNA (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Levels of dCas9 protein were uniform between strains (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Neither insertion of <italic>URA3</italic> into snR52 nor dCas9 expression in the control strains affected growth rate, although strains expressing some sgRNAs grew more slowly indicating a physiological effect (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.29878.002</object-id><label>Figure 1.</label><caption><title>Experimental strategy for sgRNA template synthesis and incorporation into yeast.</title><p>(<bold>A</bold>) An outline of the experiment. DNA templates for sgRNA production were generated using a click chemistry reaction between a single-stranded DNA oligonucleotide with a 3’ alkyne group encoding the constant region (dark blue) and a number of single-stranded DNA oligonucleotides with 5’ azido groups encoding the different variable regions (green). The resulting single-stranded DNA oligonucleotide was purified, amplified by PCR and transformed into yeast to replace the <italic>URA3</italic> selection cassette that had previously been introduced into the endogenous <italic>snR52</italic> locus. Correct insertion was confirmed by Sanger sequencing. The expression of the sgRNA is driven from the endogenous RNA polymerase III <italic>snR52</italic> promoter and processed to produce a mature sgRNA. The sgRNA couples with enzymatically dead Cas9 (dCas9, red), expressed under the control of the <italic>TDH3</italic> promoter off a plasmid, to block transcription. See Materials and methods for more detail. (<bold>B</bold>) A polyacrylamide gel visualised by UV shadowing reveals a high efficiency of the click reaction for all the <italic>HMS2</italic> constructs (see <xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref> for positions of the sgRNA binding sites). The sizes of the variable region, DNA splint, constant region and clicked product are indicated. (<bold>C</bold>) PCR efficiencies of the clicked and full-length synthetic DNA oligonucleotides as measured by qPCR with a serial dilution series. N = 3, errors are standard error of the mean (SEM), all differences are not significant p&gt;0.05. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tab 2. (<bold>D</bold>) Doubling times (min) of the indicated yeast strains grown in complete synthetic media minus leucine. C, strains constructed using clicked oligonucleotides; FLS, strains constructed using full-length synthetic oligonucleotides. N = 10, errors are SEM, *p&lt;0.05. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tabs 3–4.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29878.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Levels of dCas9 protein in the experimental strains.</title><p>Western blots showing levels of dCas9 produced in the strains expressing the indicated sgRNAs against <italic>HMS2</italic> (left panel) and <italic>GAL1</italic> (right panel). <italic>HMS2</italic> strains constructed using the clicked and control full-length synthetic DNA oligos are shown. Tubulin levels are used as a loading control. Images are taken from the same gels with the same exposure times but with some lanes spliced out (indicated with vertical lines).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig1-figsupp1-v2"/></fig></fig-group></sec><sec id="s2-2"><title>CRISPRi represses the production of antisense transcripts at <italic>HMS2</italic> and <italic>GAL1</italic></title><p>CRISPRi represses transcription when sgRNAs/dCas9 are targeted to the non-template (NT) strand next to a protospacer adjacent motif (PAM) (<xref ref-type="bibr" rid="bib23">Qi et al., 2013</xref>) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Firstly, we used an engineered version of <italic>GAL1</italic> that has a stable antisense transcript (<italic>GAL1</italic> AS) initiating within an <italic>ADH1</italic> terminator inserted into the <italic>GAL1</italic> coding region (<xref ref-type="bibr" rid="bib18">Murray et al., 2012</xref>) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). <italic>GAL1</italic> AS is present in cells grown in glucose-containing media when the <italic>GAL1</italic> gene is repressed and is reduced as cells are switched into galactose-containing media and <italic>GAL1</italic> sense is induced (<xref ref-type="fig" rid="fig2">Figure 2C</xref> lanes 1–3). We designed sgRNAs adjacent to two PAM sequences on the non-template strand near the antisense transcription start site (TSS) (AS+28NT and AS+112NT) and a third strand-specificity control sgRNA on the template strand in this region (AS + 93T) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Only sgRNA AS+112NT/dCas9 caused significant (p=0.004) reduction in <italic>GAL1</italic> antisense transcript levels, as assessed by Northern blotting (<xref ref-type="fig" rid="fig2">Figure 2C,D</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.29878.004</object-id><label>Figure 2.</label><caption><title>CRISPRi reduces antisense transcripts at <italic>GAL1</italic> and <italic>HMS2.</italic></title><p>(<bold>A</bold>) A schematic demonstrating the previously reported requirement of non-template strand targeting by the sgRNA/dCas9 complex for strand-specific transcriptional repression. Arrows indicate the direction of transcription. NT, non-template; T, template; red, dCas9; PAM, protospacer adjacent motif; green/blue, sgRNA. (<bold>B</bold>) A schematic of the engineered <italic>GAL1</italic> locus showing the site of insertion of the <italic>ADH1</italic> terminator (T, red box), the transcription start site for the stable <italic>GAL1</italic> antisense transcript and the positions of the designed sgRNAs (green vertical lines) targeting the non-template (AS+28NT, AS+112NT) and template (AS+93NT) strands with respect to antisense transcription. The position of the Northern blotting probe detecting the <italic>GAL1</italic> AS transcript is shown in purple. (<bold>C</bold>) A Northern blot showing the reduction in <italic>GAL1</italic> antisense transcript (black arrowhead) in the strain expressing sgRNA AS+112NT/dCas9 relative to the no sgRNA control (<italic>GAL1:ADH1</italic>t <italic>snR52::URA3</italic> with dCas9). sgRNAs AS+28NT and AS+93T do not alter <italic>GAL1</italic> AS levels. Samples were taken from cells grown in glucose (t = 0) and at the indicated times after transfer to galactose-containing media (min). Positions of the rRNA are indicated by the short horizontal lines. Ethidium-bromide-stained rRNA is used as loading control. (<bold>D</bold>) Quantification of Northern blotting for the <italic>GAL1</italic> AS transcript at t = 0 in the control no sgRNA strain and the strain with sgRNA AS+112NT. N = 6, errors are SEM, *p=0.004. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tabs 10–12. (<bold>E</bold>) A map of the <italic>HMS2</italic> locus showing the <italic>HMS2</italic> AS transcript, <italic>SUT650</italic> (black arrow, transcript B) and positions of the three sgRNAs targeting <italic>SUT650</italic> (green vertical lines). The position of the Northern blotting probe to detect <italic>SUT650</italic> (H1 AS) is shown by the purple line. (<bold>F</bold>) A Northern blot probed with <italic>HMS2</italic> antisense probe H1 (see schematic in (<bold>E</bold>)) showing the level of <italic>SUT650</italic> (black arrowhead, transcript B) in the no sgRNA control (<italic>snR52::URA3</italic> with dCas9) strain and strains expressing the indicated antisense-targeting sgRNAs. Deletion of <italic>XRN1</italic> allows detection of a shorter antisense transcript (B<sup>t</sup>) in the strain expressing AS+243NT. Positions of the rRNA are indicated by the short horizontal lines. *Represents cross-hybridisation with the 25S rRNA. A blot probed for the 18S rRNA is used as loading control. (<bold>G</bold>) Quantification of the level of <italic>SUT650</italic> (transcript B) reduction in the strains expressing each of the three antisense sgRNAs relative to the control no sgRNA strain. N = 4–8, errors represent SEM, *p&lt;0.05. Click-linked and full-length synthetic sgRNA AS+243NT templates behave similarly. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tabs 5–9. (<bold>H</bold>) Northern blots with a series of <italic>HMS2</italic> antisense-specific probes. A new shorter antisense transcript (B<sup>t</sup>) can be detected upon <italic>XRN1</italic> deletion in the strains expressing sgRNA AS+243NT/dCas9. Two clones of the CRISPRi strains produced using clicked (<bold>C</bold>) or full-length synthetic (FLS) DNA oligos for strain construction are shown. Positions of the antisense-specific probes (purple) and the site of sgRNA AS+243NT/dCas9 binding (green vertical line) are shown in the schematic. Positions of the rRNA on the Northern blot are indicated by the short horizontal lines. *Represents cross-hybridisation with the 25S rRNA. Ethidium-bromide-stained rRNA is used as loading control.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29878.005</object-id><label>Figure 2—figure supplement 1.</label><caption><title>TIF-seq data showing the heterogeneity in <italic>SUT650</italic> transcript start site.</title><p>Transcript start and end sites on the Crick strand of Chromosome X for <italic>SUT650</italic> as mapped by Transcript Isoform Sequencing (TIF-seq) (<xref ref-type="bibr" rid="bib21">Pelechano et al., 2013</xref>). The main <italic>SUT650</italic> transcript start site at position 705,244 bp was used in the positioning of the <italic>HMS2</italic> AS-targeting sgRNAs shown in the schematic below.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig2-figsupp1-v2"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29878.006</object-id><label>Figure 2—figure supplement 2.</label><caption><title>dCas9 is only detected at the <italic>HMS2</italic> AS+243NT sgRNA binding site.</title><p>Chromatin immunoprecipitation for dCas9 in the control strain with no sgRNA (<italic>snR52::URA3</italic> with dCas9) and in the strains with the indicated <italic>SUT650-</italic>targeting sgRNAs at the predicted sites of <italic>SUT650</italic>-targeting sgRNA binding in <italic>HMS2</italic> (sites A and B). Primer positions for qPCR are shown in purple on the locus map. Robust dCas9 signal is only detected at the binding site of the repressive sgRNA AS+243NT. Signal normalised to input and sgRNA AS+276NT. N = 3, error are SEM. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tabs 13–17.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig2-figsupp2-v2"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29878.007</object-id><label>Figure 2—figure supplement 3.</label><caption><title>Nucleosome occupancy over the <italic>HMS2</italic> sgRNA target sites does not anti-correlate with level of repression.</title><p>Nucleosome occupancy map for <italic>HMS2</italic> as measured by sequencing of a sample that has been under- and over-digested with MNase (<xref ref-type="bibr" rid="bib12">Knight et al., 2014</xref>). The schematic underneath shows the positions of the sgRNA targeting sites. Relative nucleosome occupancy at each sgRNA binding site is shown in the table for the under- and over-digested samples.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig2-figsupp3-v2"/></fig></fig-group><p>Next, we examined the <italic>HMS2</italic> locus which has a stable antisense transcript, <italic>SUT650</italic>, initiating within the 3’ coding region of <italic>HMS2</italic> (<xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>; <xref ref-type="bibr" rid="bib21">Pelechano et al., 2013</xref>). We designed three <italic>SUT650</italic>-targeting sgRNAs, located 59, 243 and 276 nucleotides downstream of the major <italic>SUT650</italic> TSS on the non-template strand (sgRNAs AS+59NT, AS+243NT, AS+276NT, respectively) (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Note that there is considerable heterogeneity in the <italic>SUT650</italic> TSS (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) and thus in some cells, sgRNA AS+59NT may be binding upstream of the <italic>SUT650</italic> TSS. AS+243NT/dCas9 significantly (p=0.011) reduced <italic>SUT650</italic> (<xref ref-type="fig" rid="fig2">Figure 2F</xref> lanes 1 and 3, 2G) and this repression was comparable for the clicked and control full-length synthetic constructs (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). However, there was no obvious effect of the other two sgRNAs/dCas9 on <italic>SUT650</italic> levels (<xref ref-type="fig" rid="fig2">Figure 2F</xref> lanes 1, 4 and 5, 2G). Consistently, we could only detect dCas9 binding to the site of sgRNA AS+243NT binding and not to the other two <italic>SUT650-</italic>targeting sgRNA binding sites tested (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). CRISPR efficiency has been linked to nucleosome occupancy (<xref ref-type="bibr" rid="bib10">Horlbeck et al., 2016b</xref>; <xref ref-type="bibr" rid="bib11">Isaac et al., 2016</xref>), but we found no correlation between the level of repression and the nucleosome occupancy (<xref ref-type="bibr" rid="bib12">Knight et al., 2014</xref>) at each of the <italic>SUT650</italic> sgRNA target regions (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). However, other factors such as sequence determinants can also influence repression (<xref ref-type="bibr" rid="bib9">Horlbeck et al., 2016a</xref>). These results at <italic>GAL1</italic> and <italic>HMS2</italic> confirm CRISPRi is suitable for reducing levels of antisense transcripts in yeast but controls are needed for each sgRNA designed to ensure that repression has been achieved.</p></sec><sec id="s2-3"><title>CRISPRi repression of <italic>SUT650</italic> induces a new shorter antisense transcript at <italic>HMS2</italic></title><p>At <italic>HMS2</italic>, sgRNA AS+243NT/dCas9 was able to reduce <italic>SUT650</italic> transcript levels significantly (<xref ref-type="fig" rid="fig2">Figure 2F,G</xref>). Since <italic>SUT650</italic> is a substrate for the major cytoplasmic 5’−3’ exonuclease Xrn1 (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, lanes 1 and 2), we investigated whether the CRISPRi-induced <italic>SUT650</italic> reduction was due to direct repression of <italic>SUT650</italic> transcription and/or a reduction in <italic>SUT650</italic> stability. Whilst <italic>SUT650</italic> was not stabilised upon <italic>XRN1</italic> deletion in the strain expressing AS+243NT/dCas9, supporting previous studies that CRISPRi operates via a transcriptional block (<xref ref-type="bibr" rid="bib23">Qi et al., 2013</xref>) (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, lanes 3 and 6, transcript B), we detected a shorter antisense transcript (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, lane 6, transcript B<sup>t</sup>). To map transcript B<sup>t</sup>, we used a series of Northern blotting probes across the locus (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). With antisense-specific probes H1 and H2 in the <italic>HMS2</italic> gene promoter and 5’ coding region, respectively, we could detect antisense transcript B<sup>t</sup>, indicating that it extends into the <italic>HMS2</italic> sense promoter. However, probe H4 at the 3’ end of the <italic>HMS2</italic> gene was unable to hybridise to B<sup>t</sup>, indicating that B<sup>t</sup> initiates upstream of this site. So whilst CRISPRi successfully blocked the original <italic>SUT650</italic>, a new Xrn1-sensitive unstable antisense transcript (B<sup>t</sup>) was created. This is potentially due to changes in the chromatin structure caused by AS+243NT/dCas9 binding to this region (<xref ref-type="bibr" rid="bib10">Horlbeck et al., 2016b</xref>; <xref ref-type="bibr" rid="bib11">Isaac et al., 2016</xref>) or by blocking <italic>SUT650</italic>, creating an environment that is permissive for transcription initiation (<xref ref-type="bibr" rid="bib18">Murray et al., 2012</xref>). We note that using probe H4 we were also unable to detect <italic>SUT650</italic> initiating from its WT start site but terminating at the AS+243 NT binding site, due to its small size (~243 nt).</p></sec><sec id="s2-4"><title>CRISPRi-induced <italic>GAL1</italic> AS repression does not affect the <italic>GAL1</italic> sense transcript</title><p>We tested whether <italic>GAL1</italic> AS repression by AS+112NT/dCas9 affected the <italic>GAL1</italic> sense transcript. Previously we mutated a TATA-like sequence to ablate antisense transcription but observed no difference in <italic>GAL1</italic> sense transcript levels in the population under repressive or activating conditions (<xref ref-type="bibr" rid="bib17">Murray et al., 2015</xref>). Using CRISPRi, we also observed no significant change in <italic>GAL1</italic> sense transcript levels or size (<xref ref-type="fig" rid="fig3">Figure 3A,B</xref>). Additionally, we observed no leaky expression of the <italic>GAL1</italic> sense transcript under repressive conditions (glucose) when the <italic>GAL1</italic> AS transcript was blocked (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, t = 0). To support a strand-specific transcriptional block of antisense transcription, <italic>GAL1</italic> sense transcript polyA site usage was unaffected by sgRNA AS+112NT/dCas9 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Furthermore, <italic>XRN1</italic> deletion in this strain also did not affect polyA site usage, ruling out a partial double-stranded transcriptional block and subsequent destabilisation of the resulting truncated sense transcript (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.29878.008</object-id><label>Figure 3.</label><caption><title><italic>HMS2</italic> and <italic>GAL1</italic> sense transcripts are differently affected by blocking of their respective antisense transcripts.</title><p>(<bold>A</bold>) A Northern blot probed for the <italic>GAL1</italic> sense transcript (black arrow) in the control strain with no sgRNA (<italic>GAL1 ADH1</italic>t <italic>snR52::URA3</italic> with dCas9) and in the strain expressing sgRNA AS+112NT/dCas9. Samples were taken from cells grown in glucose (t = 0) and at the indicated times after transfer to galactose-containing media (min). Ethidium-bromide-stained rRNA is used as a loading control. (<bold>B</bold>) Quantification of the Northern blot shown in (<bold>A</bold>) at t = 90. N = 4, error bars represent SEM, change is statistically non-significant (n.s.) p=0.062. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tabs 10–12. (<bold>C</bold>) A schematic showing the results of <italic>GAL1</italic> sense transcript 3’ end mapping by RACE in the strains indicated. All distances are shown relative to the sense TSS. Transcript cleavage and polyadenylation occurs beyond the position of the <italic>GAL1</italic> AS-blocking AS+112NT sgRNA shown (green vertical line). (<bold>D</bold>) A Northern blot probed with <italic>HMS2</italic> sense probe H1 (purple) showing the level of <italic>HMS2</italic> sense (black arrowhead, transcript A) in the no sgRNA control (<italic>snR52::URA3</italic> with dCas9) strain and strains expressing the indicated antisense-targeting sgRNAs. A truncated sense transcript (A<sup>t</sup>) was also detected in the strain expressing AS+243NT. C and C’ are read-through <italic>HMS2-BAT2</italic> transcripts (see [<xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>]). Positions of the rRNA are indicated by the short horizontal lines. Ethidium-bromide-stained rRNA is used as loading control. (<bold>E</bold>) Northern blots with a series of <italic>HMS2</italic> sense-specific probes detecting the regions indicated in the schematic. The position of the sgRNA AS+243NT/dCas9 binding site is shown (green vertical line). Positions of the rRNA are indicated by the short horizontal lines. Ethidium-bromide-stained rRNA is used as loading control.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29878.009</object-id><label>Figure 3—figure supplement 1.</label><caption><title><italic>HMS2</italic> sense-targeting sgRNAs/dCas9 are not effective at repressing <italic>HMS2</italic> sense and do not alter antisense transcript levels.</title><p>(<bold>A</bold>) A Northern blot probed with <italic>HMS2</italic> sense probe H1 (purple) showing the level of <italic>HMS2</italic> sense (black arrowhead, transcript A) in the no sgRNA control (<italic>snR52::URA3</italic> with dCas9) strain and strains expressing the indicated sense-targeting sgRNAs in the presence or absence of <italic>XRN1</italic>. Positions of the rRNA are indicated by the short horizontal lines. The 18S rRNA is used as loading control. *Represents cross-hybridisation with the 25S rRNA. (<bold>B</bold>) Quantification of the Northern blot in (<bold>A</bold>). N = 2, errors represent the SEM. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tab 6. (<bold>C</bold>) A Northern blot as (<bold>A</bold>) but probed with <italic>HMS2</italic> antisense-specific probe H1. Ethidium-bromide-stained rRNA is used as loading control. (<bold>D</bold>) Quantification of the Northern blot in (<bold>C</bold>). N = 2, errors represent the SEM. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tab 6.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig3-figsupp1-v2"/></fig></fig-group></sec><sec id="s2-5"><title>CRISPRi-induced <italic>SUT650</italic> repression truncates the <italic>HMS2</italic> sense transcript</title><p>Previous work shows that reducing <italic>SUT650</italic> transcription increases <italic>HMS2</italic> sense transcript levels (<xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>). However, blocking <italic>SUT650</italic> by AS+243NT/dCas9 did not similarly increase <italic>HMS2</italic> sense levels (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, lanes 1 and 3). To our surprise, in addition to the full-length <italic>HMS2</italic> sense transcript (A), we detected a considerably shortened <italic>HMS2</italic> sense transcript (A<sup>t</sup>). Since the combined levels of the truncated and full-length transcripts are similar to those in the strain not expressing an sgRNA, independent of the presence of <italic>XRN1</italic> (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, lanes 1 and 3 or 2 and 6), we hypothesised that the AS+243NT/dCas9 complex bound within the <italic>HMS2</italic> coding region may be causing partial premature sense transcription termination, leading to transcript A<sup>t</sup>. Thus, we mapped the 3’ end of <italic>HMS2</italic> S by Northern blotting using a series of strand-specific probes across the locus (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Both transcripts A and A<sup>t</sup> could clearly be detected using the probes upstream of the AS+243NT/dCas9 binding site (probes H1, H2, H3), but the truncated transcript was undetectable using probe H4 downstream of this site. Thus, the transcriptional block caused by AS+243NT/dCas9 is not strand-specific and re-defines the transcriptional landscape at the <italic>HMS2</italic> locus by creating a chromatin environment that is suitable for both transcription initiation and termination. To see if we could more directly target and block <italic>HMS2</italic> sense transcripts, we designed three sgRNAs to bind the non-template strand adjacent to PAM sites near the <italic>HMS2</italic> sense TSS (S+77NT, S+106NT, S+179NT) and monitored their effects on both <italic>HMS2</italic> sense and antisense transcripts (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). However, these sgRNAs gave no CRISPRi repression as indicated by the unchanged transcript levels and integrity.</p></sec><sec id="s2-6"><title>CRISPRi-induced antisense repression at <italic>HMS2</italic> and <italic>GAL1</italic> is not as efficient as previous methods</title><p>We compared the repression efficiency of CRISPRi with our previously used genetic interventions. At <italic>GAL1,</italic> mutation of a TATA-like sequence within the <italic>ADH1</italic> terminator greatly reduced the level of the <italic>GAL1</italic> antisense transcript (<xref ref-type="fig" rid="fig4">Figure 4A,B</xref>) (<xref ref-type="bibr" rid="bib17">Murray et al., 2015</xref>). Lowered <italic>GAL1</italic> AS transcript levels could result from either reduced transcription or transcript destabilisation (or a combination of the two). To differentiate between these possibilities, we deleted the major cytoplasmic 5’−3’ exonuclease <italic>XRN1</italic>. Since <italic>XRN1</italic> deletion in the TATA mutant strain only slightly increased <italic>GAL1</italic> AS levels, this suggests that most repression was at the level of transcription rather than altering transcript stability (<xref ref-type="fig" rid="fig4">Figure 4B,C</xref>). By contrast, <italic>XRN1</italic> deletion in the strain expressing AS+112NT/dCas9 did result in some upregulation of <italic>GAL1</italic> AS (<xref ref-type="fig" rid="fig4">Figure 4B,C</xref>), indicating that antisense transcript repression was not as great in this strain. Unlike at <italic>HMS2</italic> (<xref ref-type="fig" rid="fig2">Figure 2F,G</xref>), this stabilised <italic>GAL1</italic> AS transcript was the same size as in the control and so likely represents stabilisation of the transcripts escaping repression rather than novel transcripts.</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.29878.010</object-id><label>Figure 4.</label><caption><title>CRISPRi block of <italic>SUT650</italic> and <italic>GAL1</italic> AS is not as efficient as previous genetic interventions.</title><p>(<bold>A</bold>) A schematic showing the previously used genetic intervention to repress the <italic>GAL1</italic> AS transcript (<xref ref-type="bibr" rid="bib17">Murray et al., 2015</xref>). In the TATA mutant construct, a TATA box within the engineered <italic>ADH1</italic> terminator (T) is scrambled and the level of <italic>GAL1</italic> antisense transcript is reduced. (<bold>B</bold>) A Northern blot probed for the <italic>GAL1</italic> antisense transcript (black arrowhead) comparing the two methods of reducing antisense at this locus in the presence (top blot) or absence (bottom blot) of <italic>XRN1</italic>. All samples were run on the same gel and the blots were exposed to film for the same time. Samples were taken from cells grown in glucose (t = 0) and at the indicated times after transfer to galactose-containing media (min). Positions of the rRNA are indicated by the short horizontal lines. Ethidium-bromide-stained rRNA is used as loading control. (<bold>C</bold>) Quantification of the Northern blot in (<bold>B</bold>) at t = 0. N = 2, errors represent the SEM, *p=0.026, n.s. non-significant. See <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>, tab 12. (<bold>D</bold>) A schematic of the <italic>HMS2-BAT2</italic> locus, showing the <italic>HMS2</italic> sense and antisense transcripts (<bold>A and B</bold>), the <italic>HMS2-BAT2</italic> di-cistronic transcripts (<bold>C and C’</bold>) and the <italic>BAT2</italic> sense transcript (<bold>D</bold>). Cells switch between sense- and antisense-dominant states in which the indicated transcripts are produced (<xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>). (<bold>E</bold>) The <italic>HMS2-BAT2</italic> locus and associated transcripts in the wild-type (WT) strain and strains that repress the <italic>SUT650</italic> transcript. In the <italic>HMS2:URA3</italic> strain, the entire coding region of <italic>HMS2</italic> is replaced by that of <italic>URA3</italic>. (<bold>F</bold>) Northern blots comparing the efficiency of <italic>SUT650</italic> reduction by replacement of the <italic>HMS2</italic> coding region with that of <italic>URA3</italic> versus CRISPRi with sgRNA AS+243NT and the relative effects of these two strategies on the <italic>HMS2</italic> sense and <italic>BAT2</italic> transcripts shown in (<bold>E</bold>). The WT (BY4741) and <italic>HMS2.URA3</italic> strains have been transformed with plasmid pRS315 to allow for growth on complete synthetic media lacking leucine and thus comparisons with the CRISPRi strains. Positions of the rRNA are indicated by the short horizontal lines. *Represents cross-hybridisation with the 25S rRNA. Ethidium-bromide-stained rRNA is used as loading control.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29878-fig4-v2"/></fig><p>Next we compared the efficacy of AS+243NT/dCas9 with previous experiments to ablate <italic>SUT650</italic>, where we replaced the entire <italic>HMS2</italic> coding region, including the antisense TSS with the <italic>URA3</italic> coding region (<italic>HMS2:URA3</italic>) (<xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>). This successful block of <italic>SUT650</italic> transcription increased levels of the <italic>HMS2</italic> sense transcript, the di-cistronic <italic>HMS2-BAT2</italic> transcript and consequently decreased levels of the downstream gene, <italic>BAT2</italic>, due to transcriptional interference (<xref ref-type="fig" rid="fig4">Figure 4D–F</xref>). Whilst CRISPRi resulted in a similar decrease in <italic>SUT650</italic> as <italic>HMS2:URA3</italic>, neither the <italic>HMS2</italic>, <italic>BAT2</italic> nor <italic>HMS2-BAT2</italic> di-cistronic transcripts were altered (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). The discovery that whilst AS+243NT/dCas9 represses <italic>SUT650</italic>, a new unstable <italic>HMS2</italic> antisense transcript is induced and the sense transcript is prematurely terminated could explain why blocking <italic>SUT650</italic> using CRISPRi and the <italic>URA3</italic> gene body replacement strategies did not give the same results (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Thus, CRISPRi is not as effective as a genetic mutation in reducing levels of either the <italic>GAL1</italic> or <italic>HMS2</italic> AS transcripts.</p></sec><sec id="s2-7"><title>Concluding remarks</title><p>Although CRISPRi has been used to strand-specifically repress antisense transcription at <italic>GAL10</italic> (<xref ref-type="bibr" rid="bib14">Lenstra et al., 2015</xref>) and <italic>GAL1</italic> (this work), here we demonstrate that this is not true at <italic>HMS2</italic>. This may reflect the vastly different transcription levels for the galactose-inducible genes (high) compared to <italic>HMS2</italic> (low). Furthermore, a study in human K562 cells found that CRISPRi-induced repression did not correlate with which strand was targeted at 49 genes, although the mechanism behind this observation was not investigated (<xref ref-type="bibr" rid="bib7">Gilbert et al., 2014</xref>).</p><p>This work extends our previous hypothesis (<xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>), allowing us to propose that, rather than acting as a roadblock, the binding of the sgRNA/dCas9 complex at <italic>HMS2</italic> creates a new chromatin environment, either directly or indirectly via the blocking of antisense transcription, which is permissible for transcription initiation and termination. Thus, new transcription units are generated that result in novel sense and antisense transcripts of varying stabilities that are therefore not always detectable. This redefinition of the transcriptional landscape highlights the levels of controls and locus understanding needed before results from using CRISPRi can be interpreted.</p></sec></sec><sec id="s3" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resource table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) <break/>or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Gene (<italic>Sacccharomyces</italic> <break/> <italic>cerevisiae</italic>)</td><td valign="top"><italic>HMS2</italic></td><td valign="top"/><td valign="top">YJR147W; SGD ID <break/>S000003908; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003093">SCR_003093</ext-link>; SGD, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004694">SCR_004694</ext-link></td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>S. cerevisiae</italic>)</td><td valign="top"><italic>GAL1</italic></td><td valign="top"/><td valign="top">YBR020W; SGD ID <break/>S000000224; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003093">SCR_003093</ext-link>; SGD, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004694">SCR_004694</ext-link></td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>S. cerevisiae</italic>)</td><td valign="top"><italic>BAT2</italic></td><td valign="top"/><td valign="top">YJR148W; SGD ID <break/>S000003909 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003093">SCR_003093</ext-link>; SGD, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004694">SCR_004694</ext-link></td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>S. cerevisiae</italic>)</td><td valign="top"><italic>snR52</italic></td><td valign="top"/><td valign="top">SGD ID S000006443; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003093">SCR_003093</ext-link>; <break/>SGD, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004694">SCR_004694</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>S. cerevisiae</italic>)</td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref></td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref></td><td valign="top"><italic>Saccharomyces cerevisiae</italic>, <break/>NCBITaxon:1247190; <break/>SGD, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004694">SCR_004694</ext-link></td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref></td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>S. cerevisiae</italic>)</td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref></td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref></td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref></td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref></td></tr><tr><td valign="top">Antibody</td><td valign="top">Tubulin (rat monoclonal <break/>YL1/2)</td><td valign="top">Abcam</td><td valign="top">Abcam ab6160 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_305328">AB_305328</ext-link></td><td valign="top">(1:3333)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Cas9 (rabbit polyclonal)</td><td valign="top">Diagenode</td><td valign="top">C15310258 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2715516">AB_2715516</ext-link></td><td valign="top">(1:5000 Western blot); <break/>5 µl/ChIP</td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref></td><td valign="top">Eurofins Genomics</td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref></td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref></td></tr><tr><td valign="top">Recombinant DNA <break/>reagent</td><td valign="top">Plasmid with <break/>p<italic>TDH</italic>-dCas9</td><td valign="top">(<xref ref-type="bibr" rid="bib23">Qi et al., 2013</xref>) Addgene</td><td valign="top">Addgene #46920 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR:002037">SCR:002037</ext-link></td><td valign="top">PMID:23849981</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">single-stranded DNA <break/>templates for variable and <break/>constant sgRNA regions</td><td valign="top">This study</td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref></td><td valign="top">synthesised by <break/>phosphoramidite oligonucleotide <break/>synthesis with 3’-alkyne <break/>or 5’-azido modifications <break/>(<xref ref-type="bibr" rid="bib6">El-Sagheer et al., 2011</xref>)</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary files 1A,B,D,E,F</xref></td><td valign="top">Eurofins Genomics</td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary files 1A,B,D,E,F</xref></td><td valign="top">see <xref ref-type="supplementary-material" rid="supp1">Supplementary files 1A,B,D,E,F</xref></td></tr><tr><td valign="top">Commercial assay <break/>or kit</td><td valign="top">QIAquick PCR <break/>Purification Kit</td><td valign="top">Qiagen; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008539">SCR_008539</ext-link></td><td valign="top">Cat# 28106</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, <break/>drug</td><td valign="top">SYBR green qPCR <break/>master mix</td><td valign="top">Bioline</td><td valign="top">Cat# QT605-20</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Off-spotter sgRNA <break/>algorithm</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://cm.jefferson.edu/Off-Spotter//">https://cm.jefferson.edu/Off-Spotter//</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Rotor-Gene Q <break/>Series Software</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.qiagen.com/us/resources/">https://www.qiagen.com/us/resources/</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Fiji/Image J</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link></td><td valign="top">ImageJ, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link></td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s3-1"><title>sgRNA design</title><p>PAM sequences within 300 bp of the TSS in question were identified and the 20 bp immediately adjacent to these were used to design the variable regions of the sgRNAs. These sequences were run through an off-spotter algorithm (<ext-link ext-link-type="uri" xlink:href="https://cm.jefferson.edu/Off-Spotter//">https://cm.jefferson.edu/Off-Spotter//</ext-link>) to minimise any off-target effects (<xref ref-type="bibr" rid="bib22">Pliatsika and Rigoutsos, 2015</xref>). The sequence for the engineered constant region and <italic>SUP4</italic> terminator were taken from (<xref ref-type="bibr" rid="bib3">DiCarlo et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Mali et al., 2013</xref>). The <italic>HMS2</italic> sgRNA templates were synthesised as two DNA oligonucleotides to be joined by click chemistry, with the majority of the constant region on one oligonucleotide that could be used for all reactions. To increase the efficiency of the click reaction, the click linkage was designed between a dCpT dinucleotide within the Cas9 handle region. The sequences for the <italic>HMS2</italic> and <italic>GAL1</italic> sgRNA templates are shown in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>. Full-length sgRNA templates were also synthesised for the <italic>GAL1</italic> sgRNAs and as a control for the <italic>HMS2</italic> click chemistry constructs (Eurofins Genomics, Germany).</p></sec><sec id="s3-2"><title>Click chemistry</title><p>Single-stranded DNA oligonucleotides complementary to the constant and variable sgRNA regions were synthesised by standard phosphoramidite oligonucleotide synthesis with 3’-alkyne or 5’-azido modifications respectively (<xref ref-type="bibr" rid="bib6">El-Sagheer et al., 2011</xref>) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>). The click chemistry reaction was performed with a Cu<sup>1</sup> catalyst and 24–30 nt splint DNAs (<xref ref-type="bibr" rid="bib6">El-Sagheer et al., 2011</xref>). PCR was performed for second strand synthesis, amplification and incorporation of sequences homologous to the site of insertion in <italic>S. cerevisiae</italic>. PCR efficiencies were obtained using qPCR performed three times on a Corbett 6000 Rotorgene with four serial 10-fold dilutions in triplicate. Analysis was performed using Rotor-Gene Q Series Software (Qiagen, Hilden, Germany).</p></sec><sec id="s3-3"><title>Strain construction </title><p>dCas9, without fusion to a transcriptional repressor domain, was expressed from a plasmid (# 46920 Addgene [<xref ref-type="bibr" rid="bib23">Qi et al., 2013</xref>]) under the control of the <italic>TDH3</italic> promoter. The DNA templates for sgRNA production were integrated in place of an exogenous <italic>URA3</italic> cassette immediately downstream of the splice site in the endogenous <italic>snR52</italic> locus using homologous recombination followed by 5-FOA selection. Correct insertion was confirmed by genomic DNA Sanger sequencing. <italic>SNR52</italic> is a Pol III-transcribed C/D box small nucleolar RNA (snoRNA) gene and so does not undergo extensive post-transcriptional processing such as capping and polyadenylation, and transcripts from this locus are retained in the nucleus. Additionally, the locus contains a self-splicing site that produces a mature transcript without additional machinery, allowing precise production of a mature sgRNA without any unwanted extensions. Primer sequences for strain construction are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>.</p></sec><sec id="s3-4"><title>Yeast growth</title><p>The strains used in this study are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref>. Strains were grown to mid-log at 30°C in complete synthetic media lacking leucine (for dCas9 plasmid selection). For experiments studying the <italic>GAL1</italic> locus, yeast were grown to mid-log in rich media (YP 2% D/YP 2% Gal) so that the <italic>GAL1</italic> induction kinetics were similar to what we had observed previously (<xref ref-type="bibr" rid="bib18">Murray et al., 2012</xref>; <xref ref-type="bibr" rid="bib17">2015</xref>). dCas9 expression was unaffected by the temporary absence of plasmid selection (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p></sec><sec id="s3-5"><title>Yeast growth controls</title><p>Assessment of growth in liquid culture (CSM-leucine) was achieved using a Bioscreen spectrophotometer that automatically measures the optical density of cultures at 30°C every 20 min for 24 hr. Doubling times were extracted from the gradient of the curves during logarithmic growth.</p></sec><sec id="s3-6"><title>Northern blotting</title><p>Northern blotting was performed as before (<xref ref-type="bibr" rid="bib18">Murray et al., 2012</xref>; <xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>) using asymmetric PCR or in vitro transcription with T7 RNA polymerase to generate the radioactive strand-specific probes for <italic>GAL1</italic> and <italic>HMS2,</italic> respectively. Primers for these reactions are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1D</xref>. Northern blots were quantified using Fiji/ImageJ (<xref ref-type="bibr" rid="bib24">Schindelin et al., 2012</xref>), and images were acquired using a FLA 7000 phosphorimager (GE Healthcare). Images in the figures are scans of exposures to X-ray film.</p></sec><sec id="s3-7"><title>Western blotting </title><p>dCas9 expression was confirmed after each experiment using an anti-Cas9 antibody (Diagenode C15310258) at 1:5000 dilution and anti-Tubulin (Abcam ab6160) at 1:3333.</p></sec><sec id="s3-8"><title>Chromatin immunoprecipitation</title><p>Yeast cells were fixed with 1% formaldehyde (30 min, 22°C) followed by the addition of glycine to 125 mM for 5 min. Cell pellets were collected by centrifugation (3000 rpm, 5 min) before washing twice with 10 ml cold PBS. Cells were re-suspended in cold FA-150 buffer (10 mM HEPES pH 7.9, 150 mM NaCl, 0.1% SDS, 0.1% sodium deoxycholate, 1% Triton X-100) and broken using 1-ml glass beads on a MagnaLyser (Roche) at (2 × 1 min, 6000 rpm, 4°C). Fixed chromatin was sheared by sonication using a biorupter (Diagenode, 30 min, 30 s on, 30 s off, high setting), cleared by centrifugation (10,000 rpm, 15 min, 4°C) and incubated with 5 µl anti-Cas9 antibody (Diagenode C15310258) and 30 µl protein A-dynabeads pre-blocked with 200 µg/ml yeast tRNA, 200 µg/ml BSA and 200 µg/ml glycogen (15–20 hr, 4°C). Beads and attached chromatin were collected using a magnetic rack and washed with TSE-150 buffer (20 mM Tris-Cl pH 8.0, 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 1% Triton X-100) for 3 min, TSE-500 buffer (20 mM Tris-Cl pH 8.0, 500 mM NaCl, 2 mM EDTA, 0.1% SDS, 1% Triton X-100) for 3 min, LiCl buffer (0.25 M LiCl, 10 mM Tris-Cl pH 8.0, 1 mM EDTA, 1% dioxycholate, 1 % NP-40) for 15 min and twice with TE, all at 22°C. After washing, chromatin was eluted from the beads for 30 min at 65°C with elution buffer (0.1 M NaHCO3, 1% SDS). Addition of 350 mM NaCl and incubation for 3 hr at 65°C reversed the cross-links before treatment of samples with RNase A for 1 hr at 37°C and proteinase K overnight at 65°C. DNA was purified using a PCR-purification kit (Qiagen) and eluted in 400 µl 1 mM Tris-Cl pH 8.0. Input DNA was diluted accordingly. Real-time quantitative PCR (qPCR) was carried out using a Corbett 6000 Rotorgene and Sybr green qPCR master mix (Bioline). Data ([IP - no antibody control]/input) were expressed as a percentage of the input (relative to sgRNA +276 NT). Real-time qPCR primers are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1E</xref>.</p></sec><sec id="s3-9"><title>3’ RACE mapping</title><p>Mapping of the 3’ end of the <italic>GAL1</italic> sense transcript was performed as (<xref ref-type="bibr" rid="bib19">Nguyen et al., 2014</xref>). Primers are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1F</xref>.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors thank Jack Feltham for assistance with sgRNA template construction.</p></ack><sec id="s4" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Holds stock in Oxford BioDynamics Ltd., Chronos Therapeutics Ltd., and Sibelius Ltd. but these holdings present no conflict of interest with work in this article.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s5" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="sdata1"><object-id pub-id-type="doi">10.7554/eLife.29878.011</object-id><label>Source data 1.</label><caption><title>Numerical data for all graphs (referenced in Figure Legends) Tab 1.</title><p>Notes about yeast strain names Tab 2. Data supporting <xref ref-type="fig" rid="fig1">Figure 1C</xref> Tab 3. Data supporting <xref ref-type="fig" rid="fig1">Figure 1D</xref> Tab 4. Analysis of data in Tab 3 for <xref ref-type="fig" rid="fig1">Figure 1D</xref> Tab 5. Quantitation of all Northern blots for CRISPRi of <italic>HMS2</italic> AS transcripts supporting <xref ref-type="fig" rid="fig2">Figure 2</xref>–<xref ref-type="fig" rid="fig4">4</xref> Tab 6. Quantitation of all Northern blots for CRISPRi of <italic>HMS2</italic> S transcripts experiments 1 and 2 supporting <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Tab 7. Quantitation of all Northern blots for CRISPRi of <italic>HMS2</italic> S transcripts experiments 3 and 4 supporting <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Tab 8. Data analysis of comparison of CRISPRi versus genetic intervention (<italic>URA3</italic>) for HMS2 supporting <xref ref-type="fig" rid="fig4">Figure 4D–F</xref> Tab 9. <italic>HMS2</italic> sliding probes supporting <xref ref-type="fig" rid="fig3">Figure 3E</xref> and 4F Tab 10. <italic>GAL1</italic> AS CRISPRi data supporting <xref ref-type="fig" rid="fig3">Figure 3A–B</xref> Tab 11. All data for <italic>GAL1</italic> CRISPRi supporting <xref ref-type="fig" rid="fig2">Figure 2</xref>-4 Tab 12. Data analysis of comparison of CRISPRi versus genetic intervention (TATA mutant) for <italic>GAL1</italic> supporting <xref ref-type="fig" rid="fig4">Figure 4B–C</xref> Tab 13. Normalised dCas9 ChIP data at <italic>HMS2</italic> supporting <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>. Tab 14. Combined dCas9 ChIP data at <italic>HMS2</italic> for replicates 1–3 supporting <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>. Tab 15. Raw Ct data for dCas9 ChIP at <italic>HMS2</italic> replicate one supporting <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>. Tab 16. Raw Ct data for dCas9 ChIP at <italic>HMS2</italic> replicate two supporting <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>. Tab 17. Raw Ct data for dCas9 ChIP at <italic>HMS2</italic> replicate three supporting <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>. All raw data can be found at Mendeley Data: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.17632/p2652vcdz8.2">http://dx.doi.org/10.17632/p2652vcdz8.2</ext-link>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-29878-data1-v2.xlsx"/></supplementary-material><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.29878.012</object-id><label>Supplementary file 1.</label><caption><title>Supplementary Tables (referenced in the Materials and methods).</title><p>(A) Templates for sgRNAs (B) Primers for strain construction (C) <italic>Saccharomyces cerevisiae</italic> strains used in this study (D) Primers for construction of Northern blot probe templates (E) Primers for real-time qPCR at <italic>HMS2</italic> (F) Primers for 3’ RACE mapping of the <italic>GAL1</italic> sense transcript.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-29878-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.29878.013</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-29878-transrepform-v2.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname> <given-names>AR</given-names></name><name><surname>Akhtar</surname> <given-names>A</given-names></name><name><surname>Barlow</surname> <given-names>DP</given-names></name><name><surname>Bird</surname> <given-names>AP</given-names></name><name><surname>Brockdorff</surname> <given-names>N</given-names></name><name><surname>Duboule</surname> <given-names>D</given-names></name><name><surname>Ephrussi</surname> <given-names>A</given-names></name><name><surname>Ferguson-Smith</surname> <given-names>AC</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name><name><surname>Haerty</surname> <given-names>W</given-names></name><name><surname>Higgs</surname> <given-names>DR</given-names></name><name><surname>Miska</surname> <given-names>EA</given-names></name><name><surname>Ponting</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Considerations when investigating lncRNA function in vivo</article-title><source>eLife</source><volume>3</volume><elocation-id>e03058</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.03058</pub-id><pub-id pub-id-type="pmid">25124674</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birts</surname> <given-names>CN</given-names></name><name><surname>Sanzone</surname> <given-names>AP</given-names></name><name><surname>El-Sagheer</surname> <given-names>AH</given-names></name><name><surname>Blaydes</surname> <given-names>JP</given-names></name><name><surname>Brown</surname> <given-names>T</given-names></name><name><surname>Tavassoli</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transcription of click-linked DNA in human cells</article-title><source>Angewandte Chemie International Edition</source><volume>53</volume><fpage>2362</fpage><lpage>2365</lpage><pub-id pub-id-type="doi">10.1002/anie.201308691</pub-id><pub-id pub-id-type="pmid">24452865</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiCarlo</surname> <given-names>JE</given-names></name><name><surname>Norville</surname> <given-names>JE</given-names></name><name><surname>Mali</surname> <given-names>P</given-names></name><name><surname>Rios</surname> <given-names>X</given-names></name><name><surname>Aach</surname> <given-names>J</given-names></name><name><surname>Church</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>4336</fpage><lpage>4343</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt135</pub-id><pub-id pub-id-type="pmid">23460208</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sagheer</surname> <given-names>AH</given-names></name><name><surname>Brown</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Click chemistry with DNA</article-title><source>Chemical Society Reviews</source><volume>39</volume><fpage>1388</fpage><lpage>1405</lpage><pub-id pub-id-type="doi">10.1039/b901971p</pub-id><pub-id pub-id-type="pmid">20309492</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sagheer</surname> <given-names>AH</given-names></name><name><surname>Brown</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Efficient RNA synthesis by in vitro transcription of a triazole-modified DNA template</article-title><source>Chemical Communications</source><volume>47</volume><fpage>12057</fpage><lpage>12058</lpage><pub-id pub-id-type="doi">10.1039/c1cc14316f</pub-id><pub-id pub-id-type="pmid">21961113</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sagheer</surname> <given-names>AH</given-names></name><name><surname>Sanzone</surname> <given-names>AP</given-names></name><name><surname>Gao</surname> <given-names>R</given-names></name><name><surname>Tavassoli</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Biocompatible artificial DNA linker that is read through by DNA polymerases and is functional in Escherichia coli</article-title><source>PNAS</source><volume>108</volume><fpage>11338</fpage><lpage>11343</lpage><pub-id pub-id-type="doi">10.1073/pnas.1101519108</pub-id><pub-id pub-id-type="pmid">21709264</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname> <given-names>LA</given-names></name><name><surname>Horlbeck</surname> <given-names>MA</given-names></name><name><surname>Adamson</surname> <given-names>B</given-names></name><name><surname>Villalta</surname> <given-names>JE</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Whitehead</surname> <given-names>EH</given-names></name><name><surname>Guimaraes</surname> <given-names>C</given-names></name><name><surname>Panning</surname> <given-names>B</given-names></name><name><surname>Ploegh</surname> <given-names>HL</given-names></name><name><surname>Bassik</surname> <given-names>MC</given-names></name><name><surname>Qi</surname> <given-names>LS</given-names></name><name><surname>Kampmann</surname> <given-names>M</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-scale CRISPR-mediated control of gene repression and activation</article-title><source>Cell</source><volume>159</volume><fpage>647</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.09.029</pub-id><pub-id pub-id-type="pmid">25307932</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname> <given-names>LA</given-names></name><name><surname>Larson</surname> <given-names>MH</given-names></name><name><surname>Morsut</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Brar</surname> <given-names>GA</given-names></name><name><surname>Torres</surname> <given-names>SE</given-names></name><name><surname>Stern-Ginossar</surname> <given-names>N</given-names></name><name><surname>Brandman</surname> <given-names>O</given-names></name><name><surname>Whitehead</surname> <given-names>EH</given-names></name><name><surname>Doudna</surname> <given-names>JA</given-names></name><name><surname>Lim</surname> <given-names>WA</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name><name><surname>Qi</surname> <given-names>LS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes</article-title><source>Cell</source><volume>154</volume><fpage>442</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.06.044</pub-id><pub-id pub-id-type="pmid">23849981</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horlbeck</surname> <given-names>MA</given-names></name><name><surname>Gilbert</surname> <given-names>LA</given-names></name><name><surname>Villalta</surname> <given-names>JE</given-names></name><name><surname>Adamson</surname> <given-names>B</given-names></name><name><surname>Pak</surname> <given-names>RA</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Fields</surname> <given-names>AP</given-names></name><name><surname>Park</surname> <given-names>CY</given-names></name><name><surname>Corn</surname> <given-names>JE</given-names></name><name><surname>Kampmann</surname> <given-names>M</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation</article-title><source>eLife</source><volume>5</volume><elocation-id>e19760</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.19760</pub-id><pub-id pub-id-type="pmid">27661255</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horlbeck</surname> <given-names>MA</given-names></name><name><surname>Witkowsky</surname> <given-names>LB</given-names></name><name><surname>Guglielmi</surname> <given-names>B</given-names></name><name><surname>Replogle</surname> <given-names>JM</given-names></name><name><surname>Gilbert</surname> <given-names>LA</given-names></name><name><surname>Villalta</surname> <given-names>JE</given-names></name><name><surname>Torigoe</surname> <given-names>SE</given-names></name><name><surname>Tjian</surname> <given-names>R</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Nucleosomes impede Cas9 access to DNA in vivo and in vitro</article-title><source>eLife</source><volume>5</volume><elocation-id>e12677</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.12677</pub-id><pub-id pub-id-type="pmid">26987018</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaac</surname> <given-names>RS</given-names></name><name><surname>Jiang</surname> <given-names>F</given-names></name><name><surname>Doudna</surname> <given-names>JA</given-names></name><name><surname>Lim</surname> <given-names>WA</given-names></name><name><surname>Narlikar</surname> <given-names>GJ</given-names></name><name><surname>Almeida</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nucleosome breathing and remodeling constrain CRISPR-Cas9 function</article-title><source>eLife</source><volume>5</volume><elocation-id>e13450</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.13450</pub-id><pub-id pub-id-type="pmid">27130520</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname> <given-names>B</given-names></name><name><surname>Kubik</surname> <given-names>S</given-names></name><name><surname>Ghosh</surname> <given-names>B</given-names></name><name><surname>Bruzzone</surname> <given-names>MJ</given-names></name><name><surname>Geertz</surname> <given-names>M</given-names></name><name><surname>Martin</surname> <given-names>V</given-names></name><name><surname>Dénervaud</surname> <given-names>N</given-names></name><name><surname>Jacquet</surname> <given-names>P</given-names></name><name><surname>Ozkan</surname> <given-names>B</given-names></name><name><surname>Rougemont</surname> <given-names>J</given-names></name><name><surname>Maerkl</surname> <given-names>SJ</given-names></name><name><surname>Naef</surname> <given-names>F</given-names></name><name><surname>Shore</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Two distinct promoter architectures centered on dynamic nucleosomes control ribosomal protein gene transcription</article-title><source>Genes &amp; Development</source><volume>28</volume><fpage>1695</fpage><lpage>1709</lpage><pub-id pub-id-type="doi">10.1101/gad.244434.114</pub-id><pub-id pub-id-type="pmid">25085421</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavender</surname> <given-names>CA</given-names></name><name><surname>Cannady</surname> <given-names>KR</given-names></name><name><surname>Hoffman</surname> <given-names>JA</given-names></name><name><surname>Trotter</surname> <given-names>KW</given-names></name><name><surname>Gilchrist</surname> <given-names>DA</given-names></name><name><surname>Bennett</surname> <given-names>BD</given-names></name><name><surname>Burkholder</surname> <given-names>AB</given-names></name><name><surname>Burd</surname> <given-names>CJ</given-names></name><name><surname>Fargo</surname> <given-names>DC</given-names></name><name><surname>Archer</surname> <given-names>TK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Downstream antisense transcription predicts genomic features that define the specific chromatin environment at mammalian promoters</article-title><source>PLoS Genetics</source><volume>12</volume><elocation-id>e1006224</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006224</pub-id><pub-id pub-id-type="pmid">27487356</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenstra</surname> <given-names>TL</given-names></name><name><surname>Coulon</surname> <given-names>A</given-names></name><name><surname>Chow</surname> <given-names>CC</given-names></name><name><surname>Larson</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-molecule imaging reveals a switch between spurious and functional ncRNA transcription</article-title><source>Molecular Cell</source><volume>60</volume><fpage>597</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.028</pub-id><pub-id pub-id-type="pmid">26549684</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mali</surname> <given-names>P</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Esvelt</surname> <given-names>KM</given-names></name><name><surname>Aach</surname> <given-names>J</given-names></name><name><surname>Guell</surname> <given-names>M</given-names></name><name><surname>DiCarlo</surname> <given-names>JE</given-names></name><name><surname>Norville</surname> <given-names>JE</given-names></name><name><surname>Church</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RNA-guided human genome engineering via Cas9</article-title><source>Science</source><volume>339</volume><fpage>823</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1126/science.1232033</pub-id><pub-id pub-id-type="pmid">23287722</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellor</surname> <given-names>J</given-names></name><name><surname>Woloszczuk</surname> <given-names>R</given-names></name><name><surname>Howe</surname> <given-names>FS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Interleaved Genome</article-title><source>Trends in Genetics</source><volume>32</volume><fpage>57</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2015.10.006</pub-id><pub-id pub-id-type="pmid">26613890</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>SC</given-names></name><name><surname>Haenni</surname> <given-names>S</given-names></name><name><surname>Howe</surname> <given-names>FS</given-names></name><name><surname>Fischl</surname> <given-names>H</given-names></name><name><surname>Chocian</surname> <given-names>K</given-names></name><name><surname>Nair</surname> <given-names>A</given-names></name><name><surname>Mellor</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sense and antisense transcription are associated with distinct chromatin architectures across genes</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>7823</fpage><lpage>7837</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv666</pub-id><pub-id pub-id-type="pmid">26130720</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>SC</given-names></name><name><surname>Serra Barros</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>DA</given-names></name><name><surname>Dudek</surname> <given-names>P</given-names></name><name><surname>Ayling</surname> <given-names>J</given-names></name><name><surname>Mellor</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A pre-initiation complex at the 3'-end of genes drives antisense transcription independent of divergent sense transcription</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>2432</fpage><lpage>2444</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr1121</pub-id><pub-id pub-id-type="pmid">22123739</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>T</given-names></name><name><surname>Fischl</surname> <given-names>H</given-names></name><name><surname>Howe</surname> <given-names>FS</given-names></name><name><surname>Woloszczuk</surname> <given-names>R</given-names></name><name><surname>Serra Barros</surname> <given-names>A</given-names></name><name><surname>Xu</surname> <given-names>Z</given-names></name><name><surname>Brown</surname> <given-names>D</given-names></name><name><surname>Murray</surname> <given-names>SC</given-names></name><name><surname>Haenni</surname> <given-names>S</given-names></name><name><surname>Halstead</surname> <given-names>JM</given-names></name><name><surname>O'Connor</surname> <given-names>L</given-names></name><name><surname>Shipkovenska</surname> <given-names>G</given-names></name><name><surname>Steinmetz</surname> <given-names>LM</given-names></name><name><surname>Mellor</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transcription mediated insulation and interference direct gene cluster expression switches</article-title><source>eLife</source><volume>3</volume><elocation-id>e03635</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.03635</pub-id><pub-id pub-id-type="pmid">25407679</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelechano</surname> <given-names>V</given-names></name><name><surname>Steinmetz</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Gene regulation by antisense transcription</article-title><source>Nature Reviews Genetics</source><volume>14</volume><fpage>880</fpage><lpage>893</lpage><pub-id pub-id-type="doi">10.1038/nrg3594</pub-id><pub-id pub-id-type="pmid">24217315</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelechano</surname> <given-names>V</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name><name><surname>Steinmetz</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Extensive transcriptional heterogeneity revealed by isoform profiling</article-title><source>Nature</source><volume>497</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1038/nature12121</pub-id><pub-id pub-id-type="pmid">23615609</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pliatsika</surname> <given-names>V</given-names></name><name><surname>Rigoutsos</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>&quot;Off-Spotter&quot;: very fast and exhaustive enumeration of genomic lookalikes for designing CRISPR/Cas guide RNAs</article-title><source>Biology Direct</source><volume>10</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1186/s13062-015-0035-z</pub-id><pub-id pub-id-type="pmid">25630343</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname> <given-names>LS</given-names></name><name><surname>Larson</surname> <given-names>MH</given-names></name><name><surname>Gilbert</surname> <given-names>LA</given-names></name><name><surname>Doudna</surname> <given-names>JA</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name><name><surname>Arkin</surname> <given-names>AP</given-names></name><name><surname>Lim</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression</article-title><source>Cell</source><volume>152</volume><fpage>1173</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.02.022</pub-id><pub-id pub-id-type="pmid">23452860</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.29878.014</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Shilatifard</surname><given-names>Ali</given-names></name><role>Reviewing Editor</role><aff><institution>Northwestern University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;CRISPRi is not strand-specific and redefines the transcriptional landscape&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by James Manley as the Senior Editor. We have attached the reviewers' comments for you below.</p><p>As you will see, the reviewers find your study of great interest to the community, but have also suggested that the paper is technical in nature and somewhat lacks mechanistic insight. We are willing to consider a revised version of your manuscript addressing the comments/concerns of the reviewers, specifically reviewer 2.</p><p>Reviewer #1:</p><p>In recent years, transcriptional interference by antisense RNA transcription has been recognized as a relatively frequent means to regulate mRNA expression. Tools enabling antisense transcription arrest without directly affecting sense transcription are required to study the mechanism mediating this effect. The recently reported CRISPRi system, using a modified, partially defective, Cas9 (dCas9) appeared as ideally suited for this since it has been shown to be able to trigger transcription termination in a site specific and, most importantly, strand specific manner, without altering the genomic sequence.</p><p>This short report shows that this strand specificity is actually not true at all loci. In addition, it describes an example in which the binding of the guide RNA actually induces spurious transcription initiation, suggesting that it markedly perturbs the local chromatin environment.</p><p>I think that the data are suitably convincing. Note, by the way, that this referee has made the similar (unpublished) observations that the termination by this system was not strand specific at yet another locus.</p><p>Although one could argue that the main results presented in this manuscript are negative results, I personally think that they are well worth being published to warn further investigators who would wish to use this system and a short report in <italic>eLife</italic> might seem appropriate for that.</p><p>The position of the 5'-end of SUT650 seems incorrectly assigned. Indeed, if one refers to the TIF-seq data from the original Pelechano paper, the main transcription start site for SUT650 (position 705244 on the Crick strand of chromosome X; this is also consistent with the data from Malabat et al., <italic>eLife</italic>, 2015) would be located about 60 nucleotides DOWNSTREAM of the AS-44NT sgRNA binding site (position 705184). Thus, as the other SUT650 sgRNA targeting sequences, AS-44NT would actually be located within the SUT650 transcribed region, downstream from its TSS and not upstream. It could thus not be considered as a &quot;control&quot; sgRNA. Could the authors verify this point and, if this is correct, modify the text, <xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> accordingly? This would in no way modify the conclusions of the manuscript.</p><p>Reviewer #2:</p><p>In this paper by Howe et al., the authors assess the potential of CRISPRi for strand-specific transcriptional perturbation in budding yeast. They study two genes in depth – GAL1 and HMS2 – and compare the effectiveness of CRISPRi to previous approaches (for example deletion of cis-acting motifs such as the TATA box) in wt and Xrn1 deletion strains. Their primary conclusion is that CRISPRi works well in some cases and not in others and requires careful controls. For example, the authors show that the system does repress antisense transcription, but at one of the two studied loci (HMS2), an additional antisense transcript appears from a new initiation site, and the sense transcript is prematurely terminated. In addition, they present a clever tool based on click chemistry for quickly making gRNA. Although I don't find the main conclusion revelatory, I commend the authors for their thoroughness. Certainly, this message is one that bears reporting, although I am not quite convinced this result clears the bar for an <italic>eLife</italic> paper.</p><p>1) The authors show that CRISPRi represses the antisense transcript at a GAL1 model gene. They then check whether this repression has transcriptional effects on GAL1 sense transcription and they conclude there is no difference in galactose. However, previous work has shown that antisense at the GAL locus works mostly under repressive conditions. Have the authors repeated this experiment in glucose or raffinose?</p><p>2) The authors show that CRISPRi repression at the HMS2 locus results in a changed transcriptional landscape. Replacement of the HMS locus by URA does not have the same effect, and they suggest that CRISPRi binding causes these additional transcripts. However, it is unclear whether the new transcripts at HMS2 appear because of removal of the antisense, which in itself could change the chromatin landscape and thus the transcriptional landscape, or whether it arises because of binding of dCas9. The same authors have previously published that removal of the GAL10 ncRNA by genetic methods (point mutations of the transcription factor binding sites) also results in additional transcripts not visible in the wildtype (Murray et al., 2015, supplementary figure S5C). Given these findings, it remains unclear whether the new antisense transcript indeed results from the CRISPRi binding. Moreover, it is noteworthy that additional transcripts are also found in some genetic mutants. Control experiments are therefore required for both methods.</p><p>3) The Xrn1 sensitivity is a confounding factor, and I am not sure that strain should be the gold standard for CRISPRi not working. The whole point is that one can get blocking or perturbation in the absence of genetic manipulation. So, for example one concluding sentence &quot;CRISPRi is not as effective as a genetic mutation in reducing levels of either the GAL1 or HMS2 AS transcripts&quot; should end with &quot;[…] in the Xrn1 deletion.&quot;</p><p>4) In a related point, <xref ref-type="fig" rid="fig4">Figure 4C</xref> is a critical part of the argument. The lower panel needs to have significance calculated between the TATA mutant and AS+112NT, since these bars look pretty similar to this referee. Moreover, the similarity between these measurements suggests that the lower panel in <xref ref-type="fig" rid="fig4">Figure 4B</xref> is not quite a representative image.</p><p>5) Lastly, given that CRISPRi does represses the antisense transcript in both loci tested in the study in a strand-specific manner, the title is a bit misleading.</p><p>In summary, despite technical issues, I nevertheless find their argument that CRISPRi can have locus-specific effects to be convincing. However, the manuscript is mostly of a technical nature. Most experiments described are control experiments that should be done anyways when using a new method. The observations that CRISPRi can result in different transcripts is good to know when designing such experiments, but there is no proposed mechanistic insight, nor new biology that is learned from this study.</p><p>Reviewer #3:</p><p>In this manuscript Howe and collaborators in the Mellor and Brown labs explore the molecular basis of CRISPRi transcriptional interference in the context of yeast anti-sense transcription. This reviewer agrees with the authors that understanding the basis of CRISPRi in anti-sense transcription (and non-coding RNA transcription in general) is an important area of research because it is extremely difficult to establish direct causality with regard to these particular RNAs using genetic perturbations.</p><p>In the first section of their manuscript, Howe et al., describe synthesis of sgRNA constructs using &quot;click-chemistry&quot; to couple sgRNA variable regions to the constant region. The author's then use knock-in yeast strains generated using these constructs to evaluate the effects of CRISPRi on anti-sense transcription at the GAL1 and HMS2 genes. The authors observe that contrary to behaving as a transcriptional road-block when targeted to the non-template strand, dCas9 CRISPRi complexes result in unpredictable changes in chromatin and transcription, resulting in pre-mature termination of sense transcripts and shifting anti-sense transcription initiation sites. Collectively, these results clearly demonstrate that CRISPRi effects are more complex than previously reported and likely depend on locus-specific chromatin context. These observations have broad implications with respect to design of CRISPRi strategies and argue a strong case for careful characterization of transcript isoforms and promoter/termination sites before and after deploying CRISPRi. However, there are some fundamental issues with controls and some of the conclusions drawn that should be addressed before publication.</p><p>1) The authors observe that only a subset of sgRNAs targeting the non-template strand are capable of mediating repression, however, the reasons for this phenomenon are unclear. A simple explanation is that some sgRNAs are not capable of mediating stable dCAS9 interaction with chromatin. The author's should test this by performing Chromatin-Immunoprecipitation (ChIP) for dCas9 in their various sgRNA expressing lines to test if dCas9 chromatin occupancy correlates with repression. In my opinion this is an absolutely essential control for interpreting the authors' experiments.</p><p>2) This reviewer feels that increasing the sgRNA coverage across the sense/antisense transcripts in question would greatly strengthen the manuscript. In its current state, the authors test only 2 sgRNAs towards the GAL1-AS and SUT650 non-template strands, from which they obtain a single functional repressive sgRNA for each anti-sense transcript. As a strand specificity control they test 3 sgRNAs targeting the sense transcript HMS2 and show that none of these has an effect on sense or anti-sense. However, with a hit rate of ~1 in 2, this reviewer is not convinced by authors' claim that sgRNAs targeting the sense transcript have no effect on antisense transcription. Perhaps the coverage was simply too low to obtain a functional repressive sgRNA. The authors should perform high-density sgRNA tiling experiments (targeting both template and non-template) for either GAL1-AS or SUT650 (not necessary to do both loci). I feel this experiment will dramatically improve the manuscript and instill clarity into the context requirements for CRISPRi mediated repression.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.29878.015</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>In recent years, transcriptional interference by antisense RNA transcription has been recognized as a relatively frequent means to regulate mRNA expression. Tools enabling antisense transcription arrest without directly affecting sense transcription are required to study the mechanism mediating this effect. The recently reported CRISPRi system, using a modified, partially defective, Cas9 (dCas9) appeared as ideally suited for this since it has been shown to be able to trigger transcription termination in a site specific and, most importantly, strand specific manner, without altering the genomic sequence.</p><p>This short report shows that this strand specificity is actually not true at all loci. In addition, it describes an example in which the binding of the guide RNA actually induces spurious transcription initiation, suggesting that it markedly perturbs the local chromatin environment.</p><p>I think that the data are suitably convincing. Note, by the way, that this referee has made the similar (unpublished) observations that the termination by this system was not strand specific at yet another locus.</p><p>Although one could argue that the main results presented in this manuscript are negative results, I personally think that they are well worth being published to warn further investigators who would wish to use this system and a short report in eLife might seem appropriate for that.</p></disp-quote><p>We thank the reviewer for recognising the importance of this work as a warning to other researchers.</p><disp-quote content-type="editor-comment"><p>The position of the 5'-end of SUT650 seems incorrectly assigned. Indeed, if one refers to the TIF-seq data from the original Pelechano paper, the main transcription start site for SUT650 (position 705244 on the Crick strand of chromosome X; this is also consistent with the data from Malabat et al., eLife, 2015) would be located about 60 nucleotides DOWNSTREAM of the AS-44NT sgRNA binding site (position 705184). Thus, as the other SUT650 sgRNA targeting sequences, AS-44NT would actually be located within the SUT650 transcribed region, downstream from its TSS and not upstream. It could thus not be considered as a &quot;control&quot; sgRNA. Could the authors verify this point and, if this is correct, modify the text, <xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> accordingly? This would in no way modify the conclusions of the manuscript.</p></disp-quote><p>We thank the reviewer for pointing this out and apologise for our oversight. We note that there is a large heterogeneity in the position of the transcription start site for SUT650 and the one we had chosen previously (position 705149, published in Nguyen et al., 2014) is one of the many sites. We have now discussed the transcript heterogeneity in the main body of the text and included a supplementary figure with the Pelechano TIF-seq data to illustrate this (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). We have also renamed the HMS2 strains in the text and figures based on the new AS-targeting sgRNA positions relative to the major SUT650 TSS at position 705244 identified by this reviewer.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>In this paper by Howe et al., the authors assess the potential of CRISPRi for strand-specific transcriptional perturbation in budding yeast. They study two genes in depth – GAL1 and HMS2 – and compare the effectiveness of CRISPRi to previous approaches (for example deletion of cis-acting motifs such as the TATA box) in wt and Xrn1 deletion strains. Their primary conclusion is that CRISPRi works well in some cases and not in others and requires careful controls. For example, the authors show that the system does repress antisense transcription, but at one of the two studied loci (HMS2), an additional antisense transcript appears from a new initiation site, and the sense transcript is prematurely terminated. In addition, they present a clever tool based on click chemistry for quickly making gRNA. Although I don't find the main conclusion revelatory, I commend the authors for their thoroughness. Certainly, this message is one that bears reporting, although I am not quite convinced this result clears the bar for an eLife paper.</p></disp-quote><p>We thank the reviewer for their support of the message we are trying to convey to the community. We feel that <italic>eLife</italic>, with its reputation for thoroughness and research integrity, would be an ideal journal for publishing this work.</p><disp-quote content-type="editor-comment"><p>1) The authors show that CRISPRi represses the antisense transcript at a GAL1 model gene. They then check whether this repression has transcriptional effects on GAL1 sense transcription and they conclude there is no difference in galactose. However, previous work has shown that antisense at the GAL locus works mostly under repressive conditions. Have the authors repeated this experiment in glucose or raffinose?</p></disp-quote><p>As presented in <xref ref-type="fig" rid="fig3">Figure 3A</xref>, we observed no leaky expression of GAL1 sense transcript in glucose (t=0) in the absence of the antisense and the sense induction kinetics are similar to the control. We have included a sentence in the manuscript text to explain this.</p><disp-quote content-type="editor-comment"><p>2) The authors show that CRISPRi repression at the HMS2 locus results in a changed transcriptional landscape. Replacement of the HMS locus by URA does not have the same effect, and they suggest that CRISPRi binding causes these additional transcripts. However, it is unclear whether the new transcripts at HMS2 appear because of removal of the antisense, which in itself could change the chromatin landscape and thus the transcriptional landscape, or whether it arises because of binding of dCas9. The same authors have previously published that removal of the GAL10 ncRNA by genetic methods (point mutations of the transcription factor binding sites) also results in additional transcripts not visible in the wildtype (Murray et al., 2015, supplementary figure S5C). Given these findings, it remains unclear whether the new antisense transcript indeed results from the CRISPRi binding. Moreover, it is noteworthy that additional transcripts are also found in some genetic mutants. Control experiments are therefore required for both methods.</p></disp-quote><p>The point made here by this reviewer is a valid one – we are unable to infer whether it is the binding of sgRNA/dCas9 or the loss of the antisense that is causing the initiation of the new transcripts. It would be experimentally very difficult to show this and we have now clarified the two possible reasons for new transcripts in the text.</p><p>However, the main point is that, independent of what is causing the initiation of the new antisense transcript, in the CRISPRi strain, transcription is occurring in the antisense direction into the HMS2 sense promoter and so no conclusions could be made about the function of SUT650 in sense regulation in this strain. The fear is that some investigators may use the CRISPRi system without the proper controls and the current set of experiments is intended to highlight how important these controls are.</p><disp-quote content-type="editor-comment"><p>3) The Xrn1 sensitivity is a confounding factor, and I am not sure that strain should be the gold standard for CRISPRi not working. The whole point is that one can get blocking or perturbation in the absence of genetic manipulation. So, for example one concluding sentence &quot;CRISPRi is not as effective as a genetic mutation in reducing levels of either the GAL1 or HMS2 AS transcripts&quot; should end with &quot;… in the Xrn1 deletion.&quot;</p></disp-quote><p>We apologise that we were not clear about the reason for performing the experiments in the XRN1 delete and have now clarified this in the text. We chose to use the deletion of XRN1 to stabilise any transcripts that may be being produced in the CRISPRi strains but then rapidly degraded so that, if the experiment is done in an XRN1<sup>+</sup> background, the transcript could not be detected. This is important mechanistically because often it is the act of antisense transcription that may cause the effect on neighbouring/overlapping transcription units rather than the antisense transcript itself (e.g. Murray et al., 2015). In <xref ref-type="fig" rid="fig4">Figure 4B</xref>, both the TATA mutant and AS+112NT have undetectable GAL1 AS in the top panel. However, upon XRN1 deletion, a little GAL1 AS is stabilised in the TATA mutant but much more is stabilised in the AS+112NT strain. We interpret this to indicate that there is more leaky but unstable GAL1 AS transcript in the AS+112NT strain than in the TATA mutant strain and thus it is true to say that CRISPRi is not as effective as a genetic mutation in reducing levels of GAL1 AS transcriptionin the presence or absence of XRN1. The same logic can also be applied to the new unstable Xrn1-sensitive HMS2 AS transcripts that appear in the AS+243NT (previously called AS+148NT) strain.</p><disp-quote content-type="editor-comment"><p>4) In a related point, <xref ref-type="fig" rid="fig4">Figure 4C</xref> is a critical part of the argument. The lower panel needs to have significance calculated between the TATA mutant and AS+112NT, since these bars look pretty similar to this referee. Moreover, the similarity between these measurements suggests that the lower panel in <xref ref-type="fig" rid="fig4">Figure 4B</xref> is not quite a representative image.</p></disp-quote><p>We have found it very difficult to quantify blots with very low signal levels so we apologise that the image did not appear to be representative of the accompanying quantification. We have now included a more rigorous background subtraction step for the GAL1 AS Northerns and hope that the reviewer is satisfied with the new <xref ref-type="fig" rid="fig4">Figure 4C</xref>. We have also included significance values here. The same alteration in the quantification of GAL1 AS transcript levels has been repeated for the other GAL1 AS blots and <xref ref-type="fig" rid="fig2">Figure 2D</xref> has therefore been remade accordingly.</p><disp-quote content-type="editor-comment"><p>5) Lastly, given that CRISPRi does represses the antisense transcript in both loci tested in the study in a strand-specific manner, the title is a bit misleading.</p></disp-quote><p>We have shown that CRISPRi only works strand-specifically at GAL1, because at HMS2, both the sense and the antisense transcripts are blocked. However, we agree that the original title perhaps didn’t reflect this fully so have now changed it to include the words ‘at all loci’: ‘CRISPRi is not strand-specific at all loci and redefines the transcriptional landscape’.</p><disp-quote content-type="editor-comment"><p>In summary, despite technical issues, I nevertheless find their argument that CRISPRi can have locus-specific effects to be convincing. However, the manuscript is mostly of a technical nature. Most experiments described are control experiments that should be done anyways when using a new method. The observations that CRISPRi can result in different transcripts is good to know when designing such experiments, but there is no proposed mechanistic insight, nor new biology that is learned from this study.</p></disp-quote><p>We agree that most of the experiments we have done should be performed as controls for any CRISPRi experiments but are aware that, especially if CRISPRi is being used for a large-scale screen, this probably won’t be done (and may not be a practical proposition). We wish to publish this work to highlight how important it is that these controls are done or perhaps to suggest that CRIPSRi may not always be a suitable technique if the correct controls cannot be performed.</p><p>We have also added mechanistic insight in the new <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, where we have performed a ChIP experiment for Cas9 and show that dCas9 is present at the site of sgRNA binding for the sgRNA that successfully represses HMS2 AS transcript but not at those sgRNAs that do not.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>In this manuscript Howe and collaborators in the Mellor and Brown labs explore the molecular basis of CRISPRi transcriptional interference in the context of yeast anti-sense transcription. This reviewer agrees with the authors that understanding the basis of CRISPRi in anti-sense transcription (and non-coding RNA transcription in general) is an important area of research because it is extremely difficult to establish direct causality with regard to these particular RNAs using genetic perturbations.</p><p>In the first section of their manuscript, Howe et al., describe synthesis of sgRNA constructs using &quot;click-chemistry&quot; to couple sgRNA variable regions to the constant region. The author's then use knock-in yeast strains generated using these constructs to evaluate the effects of CRISPRi on anti-sense transcription at the GAL1 and HMS2 genes. The authors observe that contrary to behaving as a transcriptional road-block when targeted to the non-template strand, dCas9 CRISPRi complexes result in unpredictable changes in chromatin and transcription, resulting in pre-mature termination of sense transcripts and shifting anti-sense transcription initiation sites. Collectively, these results clearly demonstrate that CRISPRi effects are more complex than previously reported and likely depend on locus-specific chromatin context. These observations have broad implications with respect to design of CRISPRi strategies and argue a strong case for careful characterization of transcript isoforms and promoter/termination sites before and after deploying CRISPRi. However, there are some fundamental issues with controls and some of the conclusions drawn that should be addressed before publication.</p><p>1) The authors observe that only a subset of sgRNAs targeting the non-template strand are capable of mediating repression, however, the reasons for this phenomenon are unclear. A simple explanation is that some sgRNAs are not capable of mediating stable dCAS9 interaction with chromatin. The author's should test this by performing Chromatin-Immunoprecipitation (ChIP) for dCas9 in their various sgRNA expressing lines to test if dCas9 chromatin occupancy correlates with repression. In my opinion this is an absolutely essential control for interpreting the authors' experiments.</p></disp-quote><p>We are not the first to observe that, as for CRISPR, some sgRNAs are not effective for CRISPRi e.g. Lenstra et al., 2015. We do not aim to address the question of why only some sgRNAs are repressive in this paper. However, we have now performed a ChIP experiment for (d)Cas9 (see <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>) to show that we can’t detect dCas9 binding at the sgRNA sites that gave us no repression but have a strong dCas9 signal at the binding site for sgRNA AS+243NT (previously AS+148NT). Thus we have added mechanistic detail to the phenomenon observed by us and others.</p><disp-quote content-type="editor-comment"><p>2) This reviewer feels that increasing the sgRNA coverage across the sense/antisense transcripts in question would greatly strengthen the manuscript. In its current state, the authors test only 2 sgRNAs towards the GAL1-AS and SUT650 non-template strands, from which they obtain a single functional repressive sgRNA for each anti-sense transcript. As a strand specificity control they test 3 sgRNAs targeting the sense transcript HMS2 and show that none of these has an effect on sense or anti-sense. However, with a hit rate of ~1 in 2, this reviewer is not convinced by authors' claim that sgRNAs targeting the sense transcript have no effect on antisense transcription. Perhaps the coverage was simply too low to obtain a functional repressive sgRNA. The authors should perform high-density sgRNA tiling experiments (targeting both template and non-template) for either GAL1-AS or SUT650 (not necessary to do both loci). I feel this experiment will dramatically improve the manuscript and instill clarity into the context requirements for CRISPRi mediated repression.</p></disp-quote><p>We do not claim that, if we were to find an sgRNA to block HMS2 sense, that this would not also affect the antisense transcript rather that the 3 sgRNAs we tested against HMS2 sense did not repress either the sense or antisense transcripts. We apologise if this was confused in the text and have clarified this section. We included the (negative) results from the 3 sense-targeting sgRNAs again to reiterate the fact that not all sgRNAs are effective and this is an important control to do. We included the HMS2 AS data from the sense sgRNA strains as a control for the sgRNAs also not working on the template strand.</p><p>As stated above, we are not aiming to investigate what makes some sgRNAs cause effective transcript repression and others not. We do not feel that testing more sgRNAs would significantly add to the conclusions of the paper, which were that a) CRIPSRi does not always repress transcription b) CRISPRi is not always strand-specific and c) CRISPRi can induce novel transcripts that would confound any analysis. It is also relevant that the highest CRISPRi activity with unfused dCas9 was observed using PAM sites near the relevant TSSs (Qi et al., 2013) as we have done here. Using PAM sites that are more distant from the TSS is unlikely to add any insight into the conclusions we have made here.</p></body></sub-article></article>